Q3 2013 13F Holders as of 30 Sep 2013
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
1,713,402
-
Share change
-
-30,050
-
Total reported value
-
$157,531,000
-
Price per share
-
$91.95
-
Number of holders
-
11
-
Value change
-
-$2,756,651
-
Number of buys
-
5
-
Number of sells
-
2
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2013
As of 30 Sep 2013,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,713,402 shares.
The largest 10 holders included
SYSTEMATIC FINANCIAL MANAGEMENT LP, WELLS FARGO & COMPANY/MN, BANK OF MONTREAL /CAN/, Valentine Capital Asset Management, Inc., Citadel Advisors LLC, DIAM Co., Ltd., Zurcher Kantonalbank (Zurich Cantonalbank), Detwiler Fenton Investment Management LLC, PDT Partners, LLC, and LAZARD ASSET MANAGEMENT LLC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.